Translational Safety Endpoints in Nonclinical Studies

Time: 11:15 am
day: Day One

Details:

  • Determine key design considerations for AAV nonclinical studies
  • Discuss key endpoints in ocular and CNS gene therapy
  • Evaluate translational review of data for clinical trials

Speakers: